Found 476 results in Expert Content

Summary: R&D execs discuss how they've reorganized global teams, tapped new programs to fight COVID-19 and plan for the future after the pandemic.

Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. Nearly 40% of the new chemical...

Summary: Hear from experienced industry colleagues on the latest tips that will help your clients avoid critical pitfalls in early development of their drugs to best leverage CDMO...

Summary: Join this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.

Summary: The chemical stability challenges associated with many small molecule active pharmaceutical ingredients (API) necessitate the need for parenteral options for drug delivery.

Summary: This document provides both a high-level overview of Catalent’s stand-alone small molecule analytical services (on front), and a detailed list of services organized by functional area...

Summary: Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs.  New products are increasingly...

Summary: Lipid formulation and spray-dried dispersions are widely used, and proven technologies to overcome bioavailability challenges for poorly soluble molecules.  For selecting the...

Summary: Get an insight into what it takes to move a pre-clinical drug candidate to a Phase 1 clinical trial. The presentations will provide guidance on non-clinical and regulatory considerations...

Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. In a recent Pharmaceutical...